SCHEMBL14418641

SCHEMBL14418641

COC(=O)CCCc1cc(/N=N/c2ccccc2Cl)c(O)c(C(C)(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 6/20 0.41
▸ KMT2A Q03164 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ MAOB P27338 3/20 0.39
▸ MAOA P21397 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ AGTR1 P30556 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ MCL1 Q07820 1/20 0.39
▸ ACHE P22303 1/20 0.38
▸ VCAM1 P19320 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ GSK3B P49841 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14413578 0.94 GAA (0.45) GAAKMT2AMEN1MAOBMAOA
SCHEMBL5186218 0.94 GAA (0.45) GAAKMT2AMEN1MAOBMAOA
SCHEMBL14418461 0.84 CES2 (0.41) GAAKMT2AMEN1MAOBMAOA
SCHEMBL4145722 0.80 GAA (0.59) GAAKMT2AMEN1ALDH1A1LMNA
SCHEMBL5184540 0.78 CES2 (0.42) GAAKMT2AMEN1MAOBMAOA
SCHEMBL5184541 0.78 CES2 (0.42) GAAKMT2AMEN1MAOBMAOA
SCHEMBL6934736 0.76 MAPT (0.40) KMT2AMEN1ALDH1A1LMNASMN1; SMN2
SCHEMBL10756626 0.75 GAA (0.56) GAAKMT2AMEN1ALDH1A1LMNA
SCHEMBL28287984 0.73 GAA (0.57) GAAKMT2AMEN1MAOBMAOA
SCHEMBL490767 0.72 GAA (0.67) GAAKMT2AMEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070208165-A1 Process for the preparation of benzotriazoles FISCHER WALTER 2007-09-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070208165-A1 Process for the preparation of benzotriazoles CBR1, CCNT1, CYP1B1 GAA 2317/4885KMT2A 249/4885MEN1 565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback